142 related articles for article (PubMed ID: 24930650)
1. The use of oral beclomethasone dipropionate in the treatment of gastrointestinal graft-versus-host disease: the experience of the Fukuoka blood and marrow transplantation (BMT) group.
Takashima S; Eto T; Shiratsuchi M; Hidaka M; Mori Y; Kato K; Kamezaki K; Oku S; Henzan H; Takase K; Matsushima T; Takenaka K; Iwasaki H; Miyamoto T; Akashi K; Teshima T
Intern Med; 2014; 53(12):1315-20. PubMed ID: 24930650
[TBL] [Abstract][Full Text] [Related]
2. Oral beclomethasone dipropionate for the treatment of gastrointestinal chronic graft-versus-host disease.
Villanueva FN; Pérez-Simón JA; Silva FF; Caballero-Velázquez TT; Sánchez-Guijo FF; Cañizo CC; Vázquez LL; Caballero DD; San Miguel JF
Biol Blood Marrow Transplant; 2009 Oct; 15(10):1331-6. PubMed ID: 19747642
[TBL] [Abstract][Full Text] [Related]
3. Long-term use of oral beclomethasone dipropionate for the treatment of gastrointestinal graft-versus-host disease.
Iyer RV; Hahn T; Roy HN; Battiwalla M; Cooper M; Anderson B; Paplham P; Brown K; Bambach B; Segal BH; McCarthy PL
Biol Blood Marrow Transplant; 2005 Aug; 11(8):587-92. PubMed ID: 16041308
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of intractable gastrointestinal tract graft-vs-host disease with oral beclomethasone dipropionate in pediatric and young adult patients: Case reports.
Akahane K; Watanabe A; Somazu S; Harama D; Shinohara T; Kasai S; Oshiro H; Goi K; Hasuda N; Ozawa C; Sugita K; Inukai T
Medicine (Baltimore); 2022 Mar; 101(11):. PubMed ID: 35356922
[TBL] [Abstract][Full Text] [Related]
5. A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease.
Hockenbery DM; Cruickshank S; Rodell TC; Gooley T; Schuening F; Rowley S; David D; Brunvand M; Berryman B; Abhyankar S; Bouvier M; McDonald GB
Blood; 2007 May; 109(10):4557-63. PubMed ID: 17244684
[TBL] [Abstract][Full Text] [Related]
6. Oral beclomethasone dipropionate for the treatment of gastrointestinal acute graft-versus-host disease (GVHD).
Castilla C; Pérez-Simón JA; Sanchez-Guijo FM; Díez-Campelo M; Ocio E; Pérez-Persona E; López-Villar O; Vazquez L; Caballero D; San Miguel JF
Biol Blood Marrow Transplant; 2006 Sep; 12(9):936-41. PubMed ID: 16920559
[TBL] [Abstract][Full Text] [Related]
7. Oral beclomethasone dipropionate: a topically active corticosteroid for the treatment of gastrointestinal graft-versus-host disease following allogeneic hematopoietic cell transplantation.
McDonald GB
Expert Opin Investig Drugs; 2007 Oct; 16(10):1709-24. PubMed ID: 17922633
[TBL] [Abstract][Full Text] [Related]
8. Comparison of transplant outcomes from matched sibling bone marrow or peripheral blood stem cell and unrelated cord blood in patients 50 years or older.
Konuma T; Tsukada N; Kanda J; Uchida N; Ohno Y; Miyakoshi S; Kanamori H; Hidaka M; Sakura T; Onizuka M; Kobayashi N; Sawa M; Eto T; Matsuhashi Y; Kato K; Ichinohe T; Atsuta Y; Miyamura K;
Am J Hematol; 2016 May; 91(5):E284-92. PubMed ID: 26910296
[TBL] [Abstract][Full Text] [Related]
9. Oral beclomethasone dipropionate for treatment of intestinal graft-versus-host disease: a randomized, controlled trial.
McDonald GB; Bouvier M; Hockenbery DM; Stern JM; Gooley T; Farrand A; Murakami C; Levine DS
Gastroenterology; 1998 Jul; 115(1):28-35. PubMed ID: 9649455
[TBL] [Abstract][Full Text] [Related]
10. Preparation of enteric-coated capsules of beclomethasone dipropionate for patients with intestinal graft-versus-host disease and a case study.
Murakawa K; Sato T; Maeda Y; Kitamura Y; Tanimoto M; Sendo T
Acta Med Okayama; 2013; 67(5):319-24. PubMed ID: 24145732
[TBL] [Abstract][Full Text] [Related]
11. Oral beclomethasone dipropionate as an initial treatment of gastrointestinal acute graft-versus-host disease after reduced-intensity cord blood transplantation.
Miura Y; Narimatsu H; Kami M; Kusumi E; Matsumura T; Yuji K; Wake A; Miyakoshi S; Taniguchi S
Bone Marrow Transplant; 2006 Oct; 38(8):577-9. PubMed ID: 16953206
[No Abstract] [Full Text] [Related]
12. Outcome of gastrointestinal graft-versus-host disease according to the treatment response.
Tamaki M; Nakasone H; Misaki Y; Yoshimura K; Gomyo A; Hayakawa J; Kusuda M; Akahoshi Y; Ishihara Y; Kawamura K; Tanihara A; Sato M; Terasako-Saito K; Kameda K; Wada H; Kikuchi M; Kimura SI; Kako S; Kanda Y
Ann Hematol; 2018 Oct; 97(10):1951-1960. PubMed ID: 29860563
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of clinical outcomes after allogeneic bone marrow transplantation versus peripheral blood stem cell transplantation from a related donor in Japanese patients.
Tanimoto TE; Yamaguchi T; Tanaka Y; Saito A; Tajima K; Karasuno T; Kasai M; Kishi K; Mori T; Maseki N; Morishima S; Miyakoshi S; Kasai M; Ohno Y; Kim SW; Numata A; Kami M; Takaue Y; Mori S; Harada M
Br J Haematol; 2004 May; 125(4):480-93. PubMed ID: 15142119
[TBL] [Abstract][Full Text] [Related]
14. Oral beclomethasone dipropionate for treatment of human intestinal graft-versus-host disease.
Baehr PH; Levine DS; Bouvier ME; Hockenbery DM; Gooley TA; Stern JG; Martin PJ; McDonald GB
Transplantation; 1995 Dec; 60(11):1231-8. PubMed ID: 8525516
[TBL] [Abstract][Full Text] [Related]
15. Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation.
Parody R; Martino R; Rovira M; Vazquez L; Vázquez MJ; de la Cámara R; Blazquez C; Fernández-Avilés F; Carreras E; Salavert M; Jarque I; Martín C; Martínez F; López J; Torres A; Sierra J; Sanz GF;
Biol Blood Marrow Transplant; 2006 Jul; 12(7):734-48. PubMed ID: 16785063
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of oral beclomethasone dipropionate for prevention of acute graft-versus-host disease.
Martin PJ; Furlong T; Rowley SD; Pergam SA; Lloid M; Schubert MM; Horgan KJ; Storer BE
Biol Blood Marrow Transplant; 2012 Jun; 18(6):922-9. PubMed ID: 22079469
[TBL] [Abstract][Full Text] [Related]
17. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.
Schönberger S; Niehues T; Meisel R; Bernbeck B; Laws HJ; Kögler G; Enzmann J; Wernet P; Göbel U; Dilloo D
Klin Padiatr; 2004; 216(6):356-63. PubMed ID: 15565551
[TBL] [Abstract][Full Text] [Related]
18. Impact of stem cell source on allogeneic stem cell transplantation outcome in hematological malignancies.
Stamatović D; Balint B; Tukić L; Elez M; Tarabar O; Todorović M; Ostojić G; Tatomirovic Z; Ljubenov M; Marjanović S; Malesević M
Vojnosanit Pregl; 2011 Dec; 68(12):1026-32. PubMed ID: 22352263
[TBL] [Abstract][Full Text] [Related]
19. Sole Upfront Therapy with Beclomethasone and Budesonide for Upper Gastrointestinal Acute Graft-versus-Host Disease.
Frairia C; Nicolosi M; Shapiro J; Kim J; Betts BC; Fernandez HF; Locke FL; Mishra A; Nishihori T; Ochoa-Bayona JL; Perez L; Pidala J; Anasetti C
Biol Blood Marrow Transplant; 2020 Jul; 26(7):1303-1311. PubMed ID: 32361010
[TBL] [Abstract][Full Text] [Related]
20. Oral beclomethasone dipropionate as an initial treatment for stages 1-2 gastrointestinal tract acute graft-versus-host disease following unrelated cord blood transplantation.
Yamamoto H; Uchida N; Uchida Y; Nishida A; Ota H; Kageyama K; Nasu I; Wada S; Kaji D; Ishiwata K; Takagi S; Tsuji M; Asano-Mori Y; Matsuno N; Yamamoto G; Masuoka K; Izutsu K; Wake A; Yoneyama A; Makino S; Ito T; Hayashi M; Taniguchi S
Ann Hematol; 2015 Dec; 94(12):2073-5. PubMed ID: 26374433
[No Abstract] [Full Text] [Related]
[Next] [New Search]
